Levonorgestrel Apofri

Levonorgestrel, the active ingredient in Levonorgestrel Apofri, is a progestogen presented as an oral tablet for systemic use. It is employed to prevent pregnancy and can be used as emergency contraception after unprotected intercourse. It is indicated for routine contraception and as a single‑dose regimen for post‑coital use, providing a reliable, hormone‑based method to reduce the risk of implantation.

GNH USA supplies Levonorgestrel Apofri as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance.

Levonorgestrel Apofri acts within the hormonal contraceptive pathway to prevent pregnancy.

Prevention of pregnancy: provides reliable contraceptive protection when taken as prescribed. Emergency contraception: can be used after unprotected sexual intercourse to reduce the chance of pregnancy. Menstrual cycle regulation: may be prescribed to manage certain menstrual disorders such as irregular bleeding.

Levonorgestrel Apofri may cause a range of adverse reactions, which are classified by frequency and severity.

Common Side Effects: - Nausea - Headache - Breast tenderness - Irregular vaginal bleeding - Fatigue - Mood changes

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Blood clots such as deep vein thrombosis - Liver dysfunction or hepatitis - Persistent abdominal pain - Unusual or prolonged vaginal bleeding

Before prescribing Levonorgestrel Apofri, clinicians should consider several precautionary measures to ensure safe use.

Medical history review: assess for thromboembolic disorders, liver disease, or hormone‑sensitive cancers. Concurrent medication check: evaluate interactions with enzyme inducers or anticoagulants. Pregnancy status: avoid use if the patient is already pregnant. Breastfeeding: discuss potential risks with a healthcare provider. Store at ambient temperature: keep below 25°C, in the original pack, and protect from moisture.

Levonorgestrel Apofri can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Antiepileptic enzyme inducers (e.g., carbamazepine, phenytoin): may reduce contraceptive effectiveness. - Rifampin: can lower hormone levels and decrease efficacy. - Protease inhibitor antiretrovirals (e.g., ritonavir): may increase hormone concentrations, raising side‑effect risk.

Moderate Interactions (Monitor Closely): - Antifungal azoles (e.g., ketoconazole): may raise levonorgestrel plasma levels. - St. John’s Wort: may diminish contraceptive effectiveness. - Anticoagulants (e.g., warfarin): may alter bleeding risk, requiring monitoring.